-
It has long been believed, with considerable substantiation, that women have poorer results of percutaneous interventions (PCI) than men, with higher morbidity and mortality rates.
-
Following successful reperfusion for acute myocardial infarction (MI) with primary percutaneous coronary intervention (PCI), the persistence of impaired perfusion portends a poor prognosis.
-
The endothelin receptor antagonist bosentan has been shown to improve exercise tolerance, hemodynamics, and clinical deterioration in trials of patients with advanced symptoms due to pulmonary hypertension (WHO functional class III and IV).
-
Dronedarone is a new multichannel blocking agent with electrophysiologic properties similar to those of amiodarone that is under development for the treatment of atrial arrhythmias.
-
Baxter Bioscience has developed a whole-virus, two dose vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions
-
-
Although multivessel stenting is an off-label use DES, anecdotal evidence has suggested excellent short-term outcomes, comparable to those achieved with CABG.
-
A study to evaluate the effect of rosuvastatin on intravascular ultrasound derived coronary atheroma burden (ASTEROID) was designed to assess the effects of rosuvastatin monotherapy on the progression of coronary atherosclerosis in patients undergoing catheterization.
-
Bicuspid aortic valve is a common congenital abnormality that can progress to significant aortic stenosis or regurgitation, and is associated with aortic aneurysm and dissection.
-
In october, 2007, Medtronic, a leading ICD and pacemaker manufacturer, issued an updated lead safety advisory and recalled the Sprint Fidelis family of ICD leads.
